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Cerebellar learning distinguishes
inflammatory neuropathy with and
without tremor
ABSTRACT
Objectives: This study aims to investigate if patients with inflammatory neuropathies and tremor
have evidence of dysfunction in the cerebellum and interactions in sensorimotor cortex compared
to nontremulous patients and healthy controls.
Methods: A prospective data collection study investigating patients with inflammatory neuropathy
and tremor, patients with inflammatory neuropathy without tremor, and healthy controls on a test
of cerebellar associative learning (eyeblink classical conditioning), a test of sensorimotor integra-
tion (short afferent inhibition), and a test of associative plasticity (paired associative stimulation).
We also recorded tremor in the arms using accelerometry and surface EMG.
Results: We found impaired responses to eyeblink classical conditioning and paired associative
stimulation in patients with neuropathy and tremor compared with neuropathy patients without
tremor and healthy controls. Short afferent inhibition was normal in all groups.
Conclusions: Our data strongly suggest impairment of cerebellar function is linked to the produc-
tion of tremor in patients with inflammatory neuropathy. Neurology 2013;80:1867–1873
GLOSSARY
ADM 5 abductor digiti minimi; ANOVA 5 analysis of variance; APB 5 abductor pollicis brevis; CIDP 5 chronic inflammatory
demyelinating polyradiculoneuropathy; CR 5 conditioned blink responses; EBCC 5 eyeblink classical conditioning; FDI 5
first dorsal interossei; IgMPN5 immunoglobulin M paraproteinaemic neuropathy;MEP5motor evoked potential;MMNCB5
multifocal motor neuropathy with conduction block; MRC 5 Medical Research Council; ONLS 5 Overall Neuropathy Limita-
tion Scale; PAS 5 paired associative stimulation; PF 5 peak tremor frequency; SAI 5 short afferent inhibition; TMS 5
transcranial magnetic stimulation; TP 5 total power of the spectra between 1 and 30 Hz used as surrogate measure of
tremor amplitude; US 5 unconditioned stimulus; WE 5 wrist extensor muscles.
Inflammatory mediated neuropathies are common and potentially treatable.1 Tremor occurs with
immunoglobulin M paraproteinaemic neuropathy (IgMPN)2–4 and less commonly in other inflam-
matory neuropathies.5 It has been suggested that temporally distorted peripheral inputs reach a
normally functioning central processor, such as the cerebellum, which is misled into producing a
delayed second agonist burst and tremor.6–8 The involvement of the cerebellum in neuropathic
tremor is supported by functional imaging abnormalities.9 There does not seem to be a straight-
forward relationship between the development of tremor and conduction velocity.10 Further, no
relationship seems to exist between tremor and the severity of neuropathy as assessed by proprio-
ceptive loss, weakness, or fatigue.11,12 However, we have shown that although conduction velocity
does not predict the presence of tremor, it is correlated with its severity for those in whom tremor is
present.5 This indicates a second mechanism may be necessary to produce tremor.
Here we set out to explore aspects of CNS physiology in tremulous and nontremulous patients
with inflammatory neuropathies compared to healthy controls. We hypothesized that the central
compensation needed to account for delays caused by the peripheral neuropathy would most
likely depend on plastic changes within the cerebellum and connections that mediate interaction
between sensory and motor systems and therefore that patients with tremor would have evidence
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of dysfunction in the cerebellum and interac-
tions in sensorimotor cortex compared to non-
tremulous patients and controls.
METHODS Subjects. Eighteen out of 43 consecutive patients
published recently5 with a diagnosis of inflammatory neuropathy
(chronic inflammatory demyelinating polyradiculoneuropathy
[CIDP], multifocal motor neuropathy with conduction block
[MMNCB], or IgMPN) agreed to take part in all or just parts
of the study. The latter depended on contraindications to elec-
trical/magnetic stimulation and on the cumulative length of study
sessions.
Patients were divided into tremulous and nontremulous
depending on whether arm tremor was clinically detectable.
The Fahn-Tolosa-Marin scale,13 a summed Medical Research
Council score14 (MRC score; maximum 70), a sensory score15
(maximum 56), and the Overall Neuropathy Limitation Scale16
(ONLS; maximum 12) were performed.
Ten tremulous patients (mean age 60.0 [9.7] years; mean disease
duration 12.5 [8.2] years; total sensory score 41.7 [13.8]; total MRC
score 65.3 [4.2]; ONLS score 3.6 [1.3]) were studied. They were
compared with 8 nontremulous patients who did not differ in these
characteristics (mean age 63.3 [8.3] years [p 5 0.46]; mean disease
duration 14.1 [10.6] years [p5 0.72]; total sensory score 42.0 [16.1]
[p5 0.97]; total MRC score 63.2 [9.0] [p5 0.59]; ONLS score 4.2
[1.2] [p5 0.38]) (table 1). We also recruited 9 healthy age-matched
controls (mean age 59.0 [7.7] years [p 5 0.54]).
Standard protocol approvals, registrations, and patient
consents. Before inclusion in the study, written informed consent
was obtained from all participants. This study was approved by the
local Research Ethics Committee.
Electrophysiologic evaluation. Surface EMG recordings were
made with Ag-AgCl surface electrodes using a belly-tendon mon-
tage. Data were stored in a computer for display and off-line ana-
lyzed using Signal version 4.00 (and Spike version 2 for tremor
analyses).
Accelerometry and EMG for tremor. Nine patients with
tremor (5 CIDP, 2 MMNCB, 2 IgMPN) took part in this evalua-
tion. A triaxial accelerometer transducer (sensitivity 6 100 mV/G)
was attached to the dorsal surface of the middle phalanx of the index
fingers. EMG recordings were made of wrist extensor muscles (WE),
wrist flexors, abductor pollicis brevis (APB), and biceps brachii bilat-
erally. Recordings were performed 1) with arms relaxed (rest), 2) with
arms/wrists outstretched at shoulder level (posture), 3) with a 500-g
mass attached to the wrists (loading), and 4) while performing a goal-
directed task (action). Accelerometry and EMG were recorded and
analyzed for 30 seconds in each condition.
Blink reflex and eyeblink classical conditioning. Three age-
matched groups were examined: 9 healthy controls, 7 nontremulous
patients (4 CIDP, 1 MMNCB, 2 IgMPN), 9 tremulous patients
(6 CIDP, 2 MMNCB, 1 IgMPN). Tremulous and nontremulous
patients did not differ in age (p 5 0.97), disease duration (p 5
0.59), total sensory score (p 5 0.72), MRC score (p 5 0.63), or
ONLS score (p 5 0.26).
Blink reflex and R2 blink reflex recovery cycle were assessed
in all subjects according to a previously described protocol.17
Eyeblink classical conditioning (EBCC) is an associative
learning paradigm, dependent on the cerebellum for acquisi-
tion.18 The conditioning stimulus (CS) was a loud (50 dB above
auditory threshold) 2,000 Hz tone lasting 400 ms played via
binaural headphones. The CS inconsistently produced an acous-
tic startle response (“alpha blink”) occurring within 200 ms after
the CS. An electrical stimulus (unconditioned stimulus [US];
200 ms pulse width at 53 sensory threshold) was given to the
left supraorbital nerve 400 ms after the CS, eliciting a blink reflex
(unconditioned response).
Repeated pairs of CS and US at 400 ms intervals yield condi-
tioned blink responses (CR) occurring within 200 ms before the US
(see figure e-1 on the Neurology® Web site at www.neurology.org).
EMG was recorded bilaterally from orbicularis oculi. Conditioning
consisted of 7 acquisition blocks (each consisting of 9 CS-US pairs,
1 US only, 1 CS only trial). An eighth and ninth block consisted of
11 CS-only trials to measure extinction.
Short afferent inhibition and paired associative stimula-
tion. Both short afferent inhibition (SAI) and paired associative
stimulation (PAS) rely on precisely timed interactions between sen-
sory afferents and motor cortical stimulation. In healthy subjects,
these interactions occur at specific times related to the N20
response. We expected N20 responses to be delayed in our patients
and therefore we evaluated N20 latency in each subject. One
patient had to be excluded because N20 could not be identified.
N20 could be measured in all other subjects studied (expressed as
mean [SD]; healthy controls 20.3 [1.5]; neuropathic tremor 33.8
[11.5]; no tremor 32.6 [6.6]).
EMG recordings were made from the abductor APB, first
dorsal interossei (FDI), and abductor digiti minimi (ADM)
muscles of the right side. Test responses in the target muscles
were evoked by transcranial magnetic stimulation (TMS) of the
left primary motor cortex applied throughMagstim 200 magnetic
stimulators with a monophasic current waveform, connected to a
figure of 8 coil. Standard techniques were used to identify the
Table 1 Demographics and clinical characteristics
Age, y Sex Disease
Disease
duration, y
FTM
score Group Study
51 M CIDP 3 9 T T, E, S, P
66 M CIDP 11 20 T E, S, P
51 M CIDP 9 13 T T, E, S, P
63 M CIDP 30 17 T T, E, S, P
74 M CIDP 7 13 T T, E, P
70 M CIDP 14 17 T T, E, P
64 M MMNCB 12 2 T T, E
56 M MMNCB 22 29 T T, E
76 M IgM (anti-MAG positive) 13 37 T T, S, P
62 M IgM (anti-MAG negative) 4 43 T T, E, S, P
62 M CIDP 7 – NT E, S, P
51 M CIDP 28 – NT E, S, P
77 F CIDP 15 – NT E, S, P
48 M CIDP (IgG paraprotein) 7 – NT S, P
67 F CIDP 9 – NT E, P
51 F MMNCB 33 – NT E
61 M IgM (anti-MAG negative) 6 – NT E
63 F IgM kappa (anti-MAG positive)
lymphoblastic lymphoma
8 – NT E, S
Abbreviations: FTM 5 Fahn-Tolosa-Marin total score (0 [minimum] to 4 points [maximum
severity] are assigned for tremor amplitude under a variety of conditions and 0–4 points for
severity in daily activities); group NT 5 nontremulous; group T 5 tremulous; study E 5
eyeblink classical conditioning; study P 5 paired associative stimulation; study S 5 short
afferent inhibition; study T 5 tremor analysis.
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motor “hot spot” and resting motor thresholds.19 Electrical stim-
ulation was applied to the median nerve at the wrist at 300% of
perceptual threshold using a constant current generator. The
stimulus duration was 0.2 ms.
Short afferent inhibition. Three age-matched groups were
examined, 6 healthy controls, 5 nontremulous patients (4 CIDP,
1 IgMPN), and 6 tremulous patients (4 CIDP, 2 IgMPN). Trem-
ulous and nontremulous patients did not differ regarding age
(p 5 0.84), disease duration (p 5 0.82), total sensory score
(p 5 0.63), MRC score (p 5 0.90), or ONLS score (p 5 0.44).
SAI was assessed as previously described.20 We assessed the
response to a cortical stimulus alone and when preceded by condi-
tioning stimuli at 10 interstimulus intervals in reference to subjects’
N20: 218 ms, 24 ms, 22 ms, 0 ms, 12 ms, 14 ms, 16 ms,
18ms,110ms,118ms. Comparison of responses between groups
was based on motor evoked potential (MEP) area.
Paired associative stimulation. Three age-matched groups
were studied, including 6 healthy controls, 5 nontremulous pa-
tients (5 CIDP), and 8 tremulous patients (6 CIDP, 2 IgMPN).
Tremulous and nontremulous patients did not differ regarding
age (p 5 0.61), disease duration (p 5 0.72), total sensory score
(p 5 0.62), MRC score (p 5 0.96), or ONLS score (p 5 0.83).
A conditioning median nerve electrical stimulus was given
5 ms plus individual N20 (i.e., 25 ms if N20 latency was
20 ms) before a TMS pulse over the APB muscle “hot spot”
at an intensity predetermined to yield a ;1 mV resting MEP.
Two hundred paired stimuli were delivered at a rate of
0.25 Hz.21 Thirty MEPs were recorded before, immediately
after, 15 minutes and 30 minutes after PAS. Comparison of
PAS response was based on MEP area.
Data analysis and statistics. A Fourier analysis of signals
derived from accelerometry was performed to define peak tremor
frequency (PF). Total power of the spectra between 1 and 30 Hz
was used as surrogate measure of tremor amplitude (TP). All pa-
rameters were calculated for each accelerometer axis, and then
averaged. For EMG, the signal was full-wave rectified and
smoothed and Fourier analysis was performed to derive PF.
For measurement of eyeblink conditioning, CRs were
counted manually. EMG bursts were regarded as “alpha blinks”
if their amplitude exceeded 50 mV and if latency was ,200 ms
after the CS. EMG bursts were regarded as CRs if latency was
.200 ms after the CS but before the US. For the CS only trials,
EMG bursts occurring 200–600 ms after the CS were considered
CRs. Statistical analysis was performed using PASW Statistics 18
(SPSS; Quarry Bay, Hong Kong). All post hoc comparisons were
corrected by the Bonferroni method. The level of statistical sig-
nificance was pre-set at p , 0.05.
RESULTS Tremor recordings. In all 9 patients, a bilat-
eral tremor was recorded during posture and action.
Five patients had additional bilateral rest tremor.
The power spectra of accelerometry and WE EMG
showed corresponding peaks. Since there was no
side-to-side difference in PF or TP in any position
(p . 0.3), we used the mean of both sides for PF
and TP for further analyses. Mean PF and TP in the 4
recorded conditions are shown in table 2.
To compare PF and TP measured by accelerometry
at rest, posture, and action, we computed 2 repeated-
measures analyses of variance(ANOVA). For PF, there
was no effect of condition (F2,16 5 3.47; p 5 0.06).
For TP, there was an effect for condition (F1,85 6.76;
p5 0.03); however, post hoc comparisons showed no
differences (p . 0.09).
A t test for pairwise comparisons showed no dif-
ference in PF (accelerometry, WE EMG) before and
after loading (p . 0.2), indicating that loading did
not decrease tremor frequency. Five out of 9 patients
had an increase of tremor amplitude after loading by
at least 100%. However, there was no difference
regarding TP before and after loading (p 5 0.33)
on group level.
In 3 out of 9 patients (2 with IgMPN, 1 with
MMNCB), PF in the APB was more than 1 Hz lower
compared to the biceps. However, a paired t test com-
paring PF during posture in biceps and APB in the
whole group of patients showed no difference
(p 5 0.17).
Blink reflex and eyeblink classical conditioning. R2 blink
reflex recovery curves, R1 and R2 latencies, and
latency variability did not differ among the 3 groups.
Repeated-measures ANOVA with block (7) as
within-subject factor and group (3) as between-sub-
ject factor revealed an interaction of block 3 group
(F12,132 5 3.34, p , 0.001). There were also effects
of block (F6,132 5 12.2, p , 0.001) and group
(F2,22 5 16.6, p , 0.001) (figure 1). Post hoc tests
showed that tremulous patients had a lower rate of
CRs as the blocks progressed compared to healthy
controls and nontremulous patients (p , 0.001).
This difference was significant in conditioning
blocks 3–7 (figure 1). Latencies of CRs, spontaneous
blink rates, and “alpha blinks” were not different
between the groups.
SAI. Repeated-measures ANOVA with state (11) as
within-subjects factor and group (3) as between-subjects
factor showed an effect of state (F3,48 5 6.64;
p , 0.001). There was no effect of group or the
group 3 state interaction. Post hoc tests showed a
reduction in MEP size occurring at interstimulus
intervals of N20 (p , 0.001) and N2022 (p 5
0.007) (figure 2).
Table 2 Mean (SD) PF and TP (derived from
accelerometry) in the 4 recorded
conditions
Accelerometry
PF (Hz) TP (mG)
Rest 7.1 (1.6) 0.55 (1.65)
Posture 6.1 (1.6) 0.85 (2.41)
Weight 6.4 (1.4) 1.21 (2.48)
Action 5.5 (1.4) 7.48 (9.69)
Abbreviations: action 5 repetitive finger-to-nose move-
ments; PF 5 peak frequency; posture 5 arms outstretched;
rest 5 rest position; TP 5 total power; weight 5 arms out-
stretched with weight loading.
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PAS.Mean intensity to produce 1 mV MEPs was not
different between patients (56%) and controls (61%).
Repeated-measures ANOVA with time (4) and mus-
cle (3) as within-subject factors and group (3) as
between-subject factor revealed that PAS produced a
lasting increase in mean MEP area demonstrated by
an effect of time (F2,335 4.762, p5 0.014). The size
of MEP facilitation differed among groups and
muscles, indicated by an effect of group (F2,16 5
9.890, p5 0.002) and an interaction of time3 group
(F4,33 5 5.166, p 5 0.002). The interaction between
time 3 muscle 3 group (F8,62 5 3.436, p 5 0.003)
demonstrates that the effect of PAS on the homotopi-
cally (APB) and heterotopically (FDI, ADM) condi-
tioned muscles differed time-dependently between
groups (figure 3).
To further explore the conditioning effects of PAS
on MEP areas in each group, we computed separate
repeated-measures ANOVAs with time and muscle as
within-subject factors. In controls, an effect of time
(F3,155 3.212; p5 0.047) was found. The facilitatory
effect was stronger in the APB compared to the FDI/
ADM, reflected by a strong time 3 muscle interaction
(F6,30 5 7.257; p , 0.001). In patients without
tremor, a different pattern of PAS-induced changes
occurred. MEP facilitation was higher and spatial spec-
ificity was compromised as indicated by a main effect of
time (F3,125 6.570; p5 0.007) without time3 mus-
cle interaction. Patients with tremor had an effect of
time (F3,21 5 3.479; p 5 0.034) due to overall MEP
depression without time 3 muscle interaction.
Post hoc comparisons revealed that PAS induced an
increase inMEP areas compared to baseline in the APB
in controls (T15: p 5 0.023), but not in neuropathy
with and without tremor. A facilitation of the MEP
area in the ADM and FDI was only observed in
patients without tremor (T15 [FDI]: p 5 0.003;
T15 [ADM]: p 5 0.036).
DISCUSSION We demonstrate that patients with
inflammatory neuropathy and tremor differ from
patients without tremor with regard to cerebellar func-
tion and sensorimotor plasticity. We found very low
rates of EBCC in patients with inflammatory neurop-
athy and tremor compared to nontremulous patients
and healthy controls, suggesting abnormal associative
learning in the cerebellum that segregates with tremor.
We also describe an absence of normal facilitation in
TMS-evoked EMG potentials after PAS in patients
with tremor, suggesting abnormal sensorimotor cortex
plasticity. In nontremulous patients, sensorimotor
plasticity, demonstrated by facilitation of TMS-evoked
EMG potentials after PAS, occurred in neighboring
muscles but without a normal facilitatory response in
the target muscle, suggesting a lack of topographic
specificity of sensorimotor plasticity.
Tremor in our patients with inflammatory neu-
ropathies was invariably present during posture and
action. Five patients had additional rest tremor.
When present in all 3 conditions, tremor was worst
Figure 1 Eyeblink classical conditioning in the 3 groups
Mean percentage of conditioned responses of each group of subjects over the 7 condition-
ing blocks (C1–C7). E1 and E2 represent extinction blocks. Error bars represent standard
error. *Significantly lower rate of conditioned blink responses in tremulous patients com-
pared to healthy controls and to nontremulous patients.
Figure 2 Short afferent inhibition in the 3 groups
Effect of short afferent inhibition on mean conditioned/unconditioned motor evoked poten-
tial (MEP) area. *Significant inhibition at N20 and N2022 ms among all groups. Relative
values are used for the figure. Error bars represent standard error.
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during posture or action, which is in concordance
with previous reports.8,22 Previously, a lower tremor
frequency in distal compared to proximal hand
muscles in 2 out of 6 patients with paraproteinemic
neuropathy was described.8 This was also observed in
3 of our patients. However, on a group level, the peak
tremor frequency did not differ between proximal and
distal muscles.
EBCC is a form of simple associative learning that is
well-studied and for which the cerebellum is both neces-
sary and sufficient. Structural or functional impairments
of the cerebellum lead to abnormalities in acquisition of
this conditioned response.17,18,23,24 We demonstrate
abnormal EBCC in tremulous neuropathy patients that
clearly differentiates them from the normal rates of con-
ditioning in nontremulous neuropathy patients and
controls. Mean R1 and R2 latencies and latency varia-
bility did not differ between groups, making it unlikely
that desynchronization of the afferent volley alone may
be a factor in the lack of conditioned responses in the
tremulous patients. The degree of impairment of acqui-
sition of conditioned responses reported here is in line
with the degree of impairment reported in patients with
cerebellar degeneration or cerebellar lesions. A previous
study showed a delayed second agonist burst25 in
patients with IgMPN and tremor, suggesting that the
cerebellum, although intact, would be a likely candidate
for a central processor “tricked” into generating tremor
in the context of distorted mistimed peripheral signals.8
Our data instead provide evidence that the cerebellum is
not functioning normally in those patients who develop
tremor.
We were able to record somatosensory evoked
potentials, albeit delayed, in all CIDP or IgMPN
patients with tremor. This is in line with the assertion
that tremor occurs in the presence of distorted rather
than absent sensory input.8 All patients, tremulous
and nontremulous, had normal SAI as compared with
normal controls. This suggests that despite the periph-
eral sensory-motor delay due to the demyelinating neu-
ropathies, central processes have, remarkably, been able
to adapt to such delays to reset to the new latency of
the N20.
In healthy subjects, PAS causes a facilitation of
motor evoked potentials in the “target muscle” only,
lasting for 15–30 minutes. This response shares a
number of features with long-term potentiation.19
Patients with tremor showed no response to PAS.
The normal SAI in patients with tremor argues
against afferent dysfunction and associated changes
in the sensory motor cortex as sole explanation for
the abnormal PAS response. This is supported by the
findings in one tremulous CIDP patient with normal
N20 and absent PAS response. In recent work, we
have demonstrated that cerebellar suppression in
healthy subjects by transcranial direct current stimu-
lation impairs subsequent motor cortical facilitation
by PAS.26 We therefore speculate that the absent PAS
response in tremulous neuropathy patients may
reflect cerebellar dysfunction that is also responsible
for their impaired EBCC.
In patients without tremor, PAS response was also
abnormal. Facilitatory changes were seen but these
occurred in neighboring ulnar-innervated muscles
Figure 3 Paired associative stimulation in the 3 groups
Effect of paired associative stimulation (PAS) onmeanmotor evoked potential (MEP) areas in
healthy controls (white), patients with inflammatory neuropathies without tremor (gray), and
patients with inflammatory neuropathies with tremor (black). The data are plotted as a ratio
to the baseline MEP area. Error bars represent standard deviation. Ratios higher than 1 indi-
cate facilitation and ratios below 1 indicate inhibition ofMEP area. The effect of PAS onMEP
area for the abductor pollicis brevis (target) muscle (A), on the first dorsal interossei (B), and
on the abductor digiti minimi (C). *p , 0.05 paired t test comparing MEP area with baseline
(corrected for multiple comparisons by Bonferroni method).
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but not in the APB. This latter finding has not, to our
knowledge, previously been described in any other
group of subjects. It is conceivable that altered topo-
graphic representation triggered by the neuropathy
may affect sensory-motor integration required to
mediate changes associated with PAS.27,28 An addi-
tional speculation is that this unusual response to
PAS may be explained by a peripheral phenomenon
such as ephaptic transmission between peripheral
nerve fibers.
We present evidence that tremor in patients with
inflammatory neuropathy is associated with cerebellar
dysfunction. We acknowledge that generalizability is
limited by our relatively small sample size. Also, this
study does not answer the question whether the cere-
bellar abnormalities in tremulous patients are second-
ary to the presence of tremor or primary. Regarding
the latter, one possibility is that in those with tremor,
the specific antibody involved in causing the peripheral
neuropathy is capable of crossing the blood–brain bar-
rier and binding to the cerebellum. There is indirect
evidence for this in IgMPN, in which tremor is typical.
It would be of interest to look for evidence of anti-
bodies that bind to cerebellum in tremulous patients
with CIDP: they may share a common causative anti-
body for their neuropathy and the cerebellar dysfunc-
tion that drives the development of tremor.
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